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Abstract 
Potassium permanganate (KMnO4) and potassium peroxymonosulfate (Oxone®) are chemical 
oxidants widely used in natural surface waters and wastewaters for the control and removal of 
pathogens and the prevention of disease caused by bacteria. However, KMnO4 and Oxone® have 
the ability to be toxic to aquatic life. Moreover, there is limited information within literature 
about the toxicity of these oxidizing agents to non-target organisms such as the microcrustacean 
Daphnia magna (D. magna). The purpose of this study was to evaluate the acute toxicity of 
KMnO4 and Oxone® to D. magna. The focus for this work is to determine the toxic effects on 
non-target organisms using the U.S. EPA approved Whole Effluent Toxicity (WET) Test 
performed with D. magna. Controlled Release Biodegradable Polymers (CRBP) were produced 
by encapsulating KMnO4 and Oxone® in polycaprolactone (PCL) per U.S. Patent #8,519,061. 
The CRBPs have previously been shown to be effective at reducing bacteria levels for 
Escherichia coli (E. coli), Enterococci, and total coliform in contaminated water. It was 
hypothesized that the CRBP could be a potential treatment technology to treat natural surface 
waters without toxicity to aquatic life. The CRBPs were tested at 0.1g KMnO4 encapsulated in 
0.5g PCL and 0.3g Oxone® encapsulated in 0.5g PCL and released for 24h, 48h and 72h in 100-
1000ml of natural surface test water to determine the toxic effects to D. magna. The results 
showed that the WET Test using D. magna demonstrated Oxone® CRBP can cause severe toxic 
effects to non-target organisms when released at any length of time, hence indicating potential 
damaging effects on higher level aquatic life that may receive effluents treated with this strong 
oxidant. Further results show that the KMnO4 CRBP caused minimal acute toxic effect in D. 
magna when released at longer lengths of time. These findings show KMnO4 CRBP exhibit 
promising minimal toxic effects on non-target organisms during environmental remediation. 
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 CHAPTER 1 
Introduction 
1.1 Background and Theory 
Worldwide, waterborne diseases caused by impaired waters kill more people annually 
than all forms of violence, including war. Waterborne diseases cause approximately 3.1 percent 
of all deaths and 3.7 percent of disability adjusted life years worldwide (Ross, 2010). These 
numbers suggest the importance of having access to safe drinking water and environmentally 
friendly water for wild and aquatic life and the significance of reducing bacteria levels that can 
cause sickness and death to humans, animals, aquatic life, and ecological environments. 
Additionally, in the USA, it has been estimated that each year 560,000 people suffer from severe 
microbial waterborne diseases, and 7.1 million suffer from mild to moderate infections, resulting 
in an estimated 12,000 deaths a year caused by waterborne diseases such as Cholera, 
Gastroenteritis and other serious salmonellosis bacterial diseases transmitted through water 
(Cabral, 2010). Exploring remediation approaches could beneficially impact the rate at which 
humans and non-targeted organisms will be affected. Adopting more advanced practices will 
promote ecological processes and the treatment of natural surface waters and wastewaters.  
The U.S. Environmental Protection Agency (EPA) provides a summary of water quality 
assessment of each water body type, consisting of data that is reported in the National Summary 
of State Information (NSSI, 2014). In 2008-2009, the EPA conducted the National Rivers and 
Streams Assessment (NRSA), which provides information on the ecological condition of the 
nation’s rivers and streams and the key stressors that affect them. In this report, the EPA states 
that, in addition to overland flow: 
Rivers and streams shape our landscape. They supply humans with drinking water, carry 
away our wastes and used water, irrigate our crops, power our cities with 
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hydroelectricity, and offer us myriad recreational and commercial opportunities. They 
support fish and other aquatic life and provide shelter, food, and habitat for birds and 
wildlife of all types. They are the land’s vast and interconnected circulatory system, 
carrying water, sediment, and organic material from the mountains to the sea. Clean and 
healthy rivers and streams greatly enhance the quality of our lives. (EPA, 2013) 
 
According to the EPA, the number one cause of impairment in the nation’s rivers and streams is 
pathogens. Out of 980,878 miles of rivers and streams assessed, 517,877 miles were reported to 
be impaired. These impairments include bacteria such as Escherichia coli (E. coli), Enterococci 
and Total Coliform and other chemical toxins such as nitrogen, mercury and phosphorous. The 
majority of these impairments are found throughout the nation’s rivers, streams, lakes, ponds and 
other forms of natural surface waters (US EPA, 2014).   
1.2 Bacteria and Pathogens Found in Water 
To help ensure bacteria and pathogens pose minimum to no risk from waterborne 
diseases, standards and other measures set forth by the EPA are entrenched in practices to protect 
human health and aquatic life in our nation’s surface waters (EPA, 2012). Although these 
practices and other standards are in place, it remains evident that E. coli, Enterococci, and other 
pathogens such as Cryptosporidium and Legionella bacteria (Cabral, 2010) continue to reside in 
various areas of our waters even after chemical, biological or radiological treatment methods are 
applied. According to Fricker (2003), natural waters contain a myriad of bacterial species. These 
species for example Vibrio species, are a primarily aquatic bacteria that can infect humans 
(Cabral, 2010). Vibrios are very common in estuarine environments and are also found in 
freshwater habitats (Cabral, 2010) in which V. cholera is by far the most important of these 
species. Cabral (2010) states that V. alginolyticus has been isolated from several types of soft 
tissue infections occurring in human clinical specimens. The number of organisms present varies 
considerably between different water types, and it is generally accepted that sewage-polluted 
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surface waters contain greater numbers of bacteria than do unpolluted waters (Fricker, 2003). 
Wastewater discharges in fresh waters are the major source of bacteria, including pathogens 
(Cabral, 2010).  
In 2013, the EPA provided the first statistically based survey of the nation’s rivers and 
streams. This report, known as the National Rivers and Streams Assessment (NRSA): A 
Collaborative Survey, assessed pathogens including chemical pollutants such as phosphorous, 
nitrogen, mercury, and other harmful toxins that could pose relative risks resulting in degraded 
biological and recreational conditions (EPA, 2013).  The EPA in the NRSA Report indicated that 
“phosphorus, nitrogen, and streambed sediments in particular have widespread and severe 
impacts; reducing levels of these constituents will significantly improve the biological health of 
rivers and streams.” (NRSA, 2013, p. 11). The findings of the report showed that 55% of the 
nation’s rivers and streams are in poor condition and do not support healthy populations of 
aquatic life due to widespread pollution impairments (EPA, 2013), and therefore, necessitates 
improvement for the physical, social and environmental well-being of our society. In addition, 
the EPA’s NRSA survey noted that more than half of the nations river’s and streams “exhibit 
poor conditions” (NRSA, p.11).  
1.3 Geographical Range of Pollution   
 Out of the three major climate regions assessed: 1) Eastern Highlands, 2) Plains and 
Lowlands, and 3) the West, the East Highlands is reported to be in the worst biological condition 
(NRSA, 2013, pp. 11-12). In this region, 62.7% of its rivers and streams impaired with high 
levels of mercury, phosphorous and other chemical toxins that pose human health risks (NRSA, 
2014, p.13). Sources of these pollutants include runoff from agriculture farms, urban activities, 
industry, acid rain and airborne pollutants generated by human activities (Carpenter & Caraco, 
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1998). In aquatic ecosystems, over enrichment with phosphorous and nitrogen causes a wide 
range of problems, including toxic algal blooms, loss of oxygen, fish kills, loss of seagrass beds 
and other aquatic vegetation (Carpenter & Caraco, 1998). These contaminants can also be a 
stressor such as on physical habitats of wildlife, fish, and aquatic organisms.  According to the 
2008-2009 National Rivers and Streams Assessment conducted by the EPA, levels of mercury 
have reached and exceeded 13,144 miles of the nation’s rivers and have exceeded the 
Enterococci bacteria threshold levels established by the EPA to protect human health (p. 13).  
Figure 1 depicts three climatic regions corresponding to major climate and landform patterns (the 
West, Plains and Lowlands, and Eastern Highlands) that are used to report NRSA results. 
  
 
Figure 1.1 Major National Rivers and Stream Assessment, 2008-2009 climate regions. 
The National Summary of States Information has also assessed the nation’s lakes, 
reservoirs, and ponds. Out of a total of 17,908,520 acres assessed, 12,117,213 acres were found 
to be impaired (NRSA, 2014). The EPA and states are grappling with new and more stringent 
water quality standards and parameters for different forms of contaminants found in our waters 
due to these alarming numbers. These lakes are widely used for swimming, boating, and other 
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recreational activities, but numerous microbial organisms, toxins and other contaminants cause 
their impairment, which in turn can affect human health. These findings suggest the need to 
address the many sources of these contaminants, including runoff from urban areas, agricultural 
practices, and wastewater. Controlling the quality of runoff would ensure healthier waters for 
future generations. Such a study may also find a cost effective way to treat impaired waters 
(EPA, 2013). 
Due to the increased number of polluted waters within the United States, feasible 
solutions must be explored to address urban runoff, agricultural waste, and wastewater streaming 
from sewage or industry in order to prevent human health and environmental exposures for 
present and future generations (EPA, 2013). Efforts to address these concerns date back to the 
1972 Clean Water Act, which implemented quality standards and established protection of the 
beneficial uses of water such as swimming, maintaining fish and other aquatic life, and providing 
drinking water for people, livestock and wildlife (EPA, 2013). Although the Clean Water Act of 
1972 resulted in many successes in reforming practices and standards to address the harm that 
generations of population growth and industrial development has inflicted upon the nation’s 
waterways, further advances in water quality improvements are imperative. This is evident in 
statements made in a congressional testimony comprised of challenges facing the EPA that 
“bears on its ability to effectively manage, oversee, and enforce environmental laws, including 
the Clean Water Act.”(Najjum, 2009) Most importantly, more efforts should be focused on 
advancements in research and technologies that will aid significantly in countless water quality 
improvements with additional improved cost-effective technologies.  Innovative technology 
partnerships to emphasize the treatment of centralized and distribution systems, urban runoff, 
and nonpoint source pollution prevention should be encouraged.  
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1.4 Controlled Release Biodegradable Polymers (CRBP) 
Controlled release biodegradable polymers containing chemical oxidants are a novel 
treatment method for wastewater (Luster-Teasley et al., 2009). For this method, oxidants are 
slowly deposited into impaired water systems as a form of treatment. The benefit of using a 
controlled release biodegradable polymer for natural surface water and wastewater treatment 
consists of its ability to be placed at the site of contamination and directly treat the specific area 
for an extended period. Another benefit to using a controlled release polymer for treatment is that 
these chemicals are able to degrade into the environment and are constructed for specific need.  
1.5 Thesis Scope 
 Chemical oxidants are typically used in gaseous and liquid form to treat groundwater and 
soils contaminated with high levels of chemicals. North Carolina A&T State University was 
recently awarded United States Patent No. 8,519,061 for a controlled release chemical oxidation 
polymer system to remediate wastewater. This "environmental pill" is able to slowly release 
either KMnO4 or Oxone® at controlled rates. The biodegradable polymer in conjunction with the 
oxidants is effective in reducing bacteria concentrations in wastewater and the improvement of 
color and odor for extended periods of time. This new technology can potentially be a method to 
control the release of oxidants and thus reduce environmental, health and safety risks to the 
public by improving public access to one of society’s most valuable resources -- clean and 
bacteria-free water.  
 This thesis research will evaluate the toxicity of water treated with two chemical 
oxidants, KMnO4 and Oxone®, using the EPA Whole Effluent Toxicity (WET) Test using 
daphnia magna. The goal for this research is to determine the effective concentration levels and 
potential environmental toxicity: (1) if contaminated wastewater is treated with the oxidants and 
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returned to natural waters containing aquatic life and (2) if the technology is used for in-situ 
treatment of impaired lakes, rivers, and streams containing aquatic life. This work will provide 
guidance for the safe handling of this form of reclaimed wastewater. It will answer questions as 
to whether treated wastewater must be reused on the property or if treated water can be returned 
directly to surrounding natural waterways. This study therefore is key to understanding the 
potential and the limitations for reuse of the treated wastewater. Previous studies (Taylor, 2012), 
have indicated that the oxidant treated wastewater can be used for irrigation with little to no 
impact to plant-life; however, the question remains for the impact or toxicity to aquatic life and 
to determine the toxicity of the CRBP to aquatic life if the polymer is used in a natural system 
(i.e. surface water at a park). 
The order for the thesis is as follows: Chapter 2 will summarize the literature addressing 
relevant information necessary to understand water contamination consisting of different types 
and levels of bacteria, the reduction of bacteria with technological treatment methods, and the 
significance of EPA’s Whole Effluent Toxicity (WET) Testing. Chapter 3 will present the 
materials and methods consisting of detailed steps taken to conduct experimental objectives and 
designs. Chapter 4 provides the findings and results from the study, including the best forms of 
surface water and wastewater treatment; and finally, Chapter 5 will provide recommendations for 
future studies. 
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 CHAPTER 2 
Literature Review 
2.1 Introduction 
This thesis research involves evaluating the treatment of wastewater and natural water 
(i.e. streams, rivers, ponds, and lakes) with the use of the chemical oxidants, KMnO4 and 
Oxone®. KMnO4 and Oxone® are oxidizing agents, which are encapsulated in PCL, providing a 
controlled release (CR) drug delivery agent. The controlled released biodegradable polymer 
(CRBP) is hypothesized to treat both wastewater and natural water treatment systems in which 
aquatic organisms may or may not exist. Wastewater will have little to no higher level aquatic 
life; however, natural water that is impaired with fecal bacteria may have an assortment of 
aquatic life living within the water.  
Therefore, the goal for this work is to assess the potential toxicity of the CR oxidants if 
released into impaired waters containing aquatic organism. D. magna will represent a freshwater 
non-target organism to aid in determining alternatives to delay the progression of contamination 
and increase avoidance to bacteria invading wastewaters and natural waters, in addition to aiding 
in the reduction of bacteria exposed aquaculture environments. These experiments are carried out 
in toxicity testing conditions and will be compared and contrasted against other related works. 
Many experimental studies have been made on the influence of different chemical substances on 
the toxicity of aquatic organisms. Only a few publications have assessed a standard toxicity test 
on the acute toxicity associated with the use of KMnO4 and Oxone® to non-targeted organisms 
such as D. magna. This literature review will review the background for water contamination 
with fecal bacteria, chemical oxidants, and the CRBP technology-including a discussion about 
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the polymer used, oxidants selected for bacteria treatment, and potential toxicity of the CRBP 
system. 
2.2 Bacteria  
According to literature, pollutants have contaminated many of the nation’s rivers and 
lakes. Industrial plants and municipal sewage treatment plants directly discharge some of these 
pollutants while others come from polluted runoff in urban and agricultural areas, and some are 
the result of historical contamination (Keyser, 1997). Importantly, bacteria and pathogen 
contamination are a growing concern due to large temporal and spatial variations in 
concentrations and diverse sources of bacteria in our nations waters (He, Lu, & Shi, 2007). The 
Centers for Disease Control (CDC) has identified bacteria and pathogen water contamination as 
major causes of water related outbreaks, triggering gastrointestinal illnesses such as: diarrhea, 
nausea, stomachaches, and vomiting. These microbial yields often impact recreational water use, 
hence making areas undesirable for swimming or fishing, while killing natural aquatic organisms 
in these ecosystems.  There are numerous types of bacteria that contribute to the contamination 
of water and the spread of disease. Some of these microorganisms include coliform bacteria. 
Coliforms enter water supplies from the direct disposal of waste into streams or lakes, or from 
runoff from wooded areas, pastures, feedlots, septic tanks, or sewage plants into streams (Keyser, 
1997; Baxter-Potter & Gilliland, 1998).  
Coliforms will be one of the first bacteria present in the water should contamination 
occur, and they will be in much larger quantities than some pathogenic microbes that may be 
present. Therefore, coliforms act as indicators of possible contamination (Keyser, 1997). E. coli, 
and Enterococci. Classified as fecal bacterial indicators, these microorganism groups allow for 
the detection of possible waterborne illnesses. Total coliform is rod-shaped bacteria, which 
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include a related group of bacterial species including: E. coli, Enterobacter, Klebsiella, and 
Citrobacter. Enterococci are gram-positive bacteria commonly found in the feces of warm-
blooded animals, including humans. The cell membrane is comprised of peptidoglycan layers 
that form a thick outer shell and is more resistant to remedial treatment than E. coli, and Total 
Coliform (Rogers, 2012).  Enterococci bacteria are used to indicate water contamination by fecal 
waste and are also used to evaluate recreational water quality and health risks in aquatic 
environments. Sustainable eco-friendly methods to efficiently treat contaminated water systems 
while also help mitigate these ongoing wastewater issues must be developed.  
Over many years of research, recreational water quality has been assessed by using 
various water quality bacterial indicators such as Total Coliform, fecal coliform (E. coli), and/or 
Enterococci. The Clean Water Act of 1970 requires that a Total Maximum Daily Load (TMDL) 
is measured and tracked for bacteria impaired water bodies. He et al. (2007) suggests that the 
development and implementation of bacterial TMDLs has prove challenging due to unknown 
sources of indicator bacteria.  According to a study done by He, Lu et al. (2007), they found that 
bacteria indicator levels in pond water were significantly higher than bacteria levels in flowing 
waters, hence resulting in pond water sediments containing a greater amount of indicator 
bacteria. Therefore, point sources (i.e. municipal wastewater treatment plants, sewage spills and 
permitted discharges) and nonpoint sources (i.e. agricultural runoff, animal waste, human waste, 
commercial and residential storm water runoff) pollution contribute to the bacterial numbers in 
water bodies (Carpenter & Caraco, 1998). It is important to consider practical and applicable 
treatment methods, while developing and implementing strategies to reduce their numbers in 
recreational water bacteria and pathogen-impaired water bodies.  
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2.3 Chemicals and Oxidation 
Chemical oxidants, or Advanced Oxidation Technologies, are effective chemical 
oxidations processes G. Anipsitakis and Dionysios (2003) that allow for this occurrence. 
Chemical oxidation is a process that modifies the structure of pollutants through the addition of 
an oxidizing agent. During oxidation, one or more electrons transfer from the oxidant to the 
targeted pollutant that is further destroyed. Chemical oxidants provide an innovative and highly 
cost effective method for treating contaminated waters and are beneficial for remediating a wide 
variety of chemical and biological contaminates.  
Chemical oxidants are highly reactive, non-selective chemicals that generate hydroxyl 
radicals that are able to degrade environmental contaminants (S. Luster-Teasley, Shah, Onochie, 
& Shirley, 2010). The oxidation process has proven effective for rapid treatment of many waste 
water issues, and is currently being used for application at large industrial and municipal 
treatment facilities across the U.S.  Certain studies where oxidants are being coupled with 
transition metals used to treat hazardous substances in water show the potential of oxidizing 
agents to readily attack and degrade both organic and microbial contamination in water (G. P. 
Anipsitakis, 2005). A study by Doan et al. (2013) expressed that chemical oxidation was applied 
to treat contaminated sediments, where results showed a 2-log decrease in the number of 16S 
rRNA gene of total bacteria in the sediment having the lowest organic matter content. 
Contaminant degradation rates were monitored in other studies. The contaminant concentrations 
were significantly reduced by a polymer- chemical oxidant combination without inhibition of 
degradation rates (Smith, Silva, Munakata-Marr, & McCray, 2008).  
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2.4 Polycaprolactone 
Polycaprolactone (PCL) is a semi-crystalline polymer that is biodegraded by living 
organisms (Woodruff & Hutmacher, 2010). Due to its biodegradable properties, PCL has been 
used as a controlled release polymer for drug delivery applications, and has been estimated to 
have total degradation from 2-4 years (Woodruff & Hutmacher, 2010; Taylor, 2012). The article 
by Woodruff and Hutmacher (2010) noted that PCL has a very low melting point and a transition 
glass temperature of around 60°C with exceptional blend capabilities. Tucker and Johnson 
(2004) carried out an investigation of PCL and other blends, finding after 20 days of incubation 
PCL composites were almost completely biodegraded at 60% degradation. When used as a 
controlled release, PCL’s characteristics make it beneficial including low melting point and 
blend capabilities, controlled degradation kinetics, as well as easy formability through physical 
manipulation for shaping purposes. This distinguishes PCL as one of the most attractive and 
versatile biodegradable plastics (Chien & Yang, 2013). Figure 2.2 shows the molecular formula 
of PCL, which includes five non-polar methylene groups and a polar ester group. 
 
Figure 2.1 Polycaprolactone (PCL)   
A research study investigating the effectiveness of progesterone encapsulated in PCL as a 
controlled release drug delivery agent was investigated by Salmoria et al. (2009). Progesterone is 
a steroid hormone that is used for endometrial cancer treatments, and as contraception control. 
Controlled release polymers use similar controlled release drug delivery technology to release 
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oxidants to disinfect and treat water systems. According to Puoci (2008), polymer delivery 
systems have helped the agriculture industry combat viruses and other crop pathogens, allowing 
lower doses to be used and to protect the environment to reduce pollution and cleanup existing 
pollutants. Additional advantages to using PCL is its bulk degradation capability with no residual 
side effects due to PCL’s half-life being twenty days. This allows the polymer to diffuse over 
time without affecting the molecular weight of the internal bulk of the polymer, which generally 
continues to remain unchanged over the degradation period (Woodruff & Hutmacher, 2010). 
Bulk degradation transpires when water penetrates the entire polymer, causing hydrolysis 
throughout the entire structure, which makes it suitable for water treatment purposes (Woodruff 
& Hutmacher, 2010). Another advantage includes PCL’s predictability, giving desirable release 
rates, which can be predetermined. Rogers (2012) found this to be true when investigating the 
release rates of polymer blends developed in Dr. Stephanie Luster-Teasley’s research group 
using oxidants. This led to discovering a predetermined release rate of oxidizing agents being 
released from a polymer composited structure. Additionally, PCL can easily be manufactured 
and manipulated into a large range of shapes and sizes. It is also relatively inexpensive for 
production and is FDA approved.  
2.5 Potassium Permanganate 
Potassium permanganate (KMnO4) is made up of dark purple odorless crystals, and is 
soluble in water-chlorinated solvents with by-products of its use being environmentally harmless. 
It can be used as an oxidizing agent, bleach or dye (Kang, Hua, & Rao, 2004). KMnO4 can be 
used to control taste, odor, and to control biological growth in treatment plants. It is also widely 
used in aquaculture for the control and removal of parasites and in the prevention of diseases 
caused by bacteria and fungi (Franca, 2011). KMnO4 solution is often added to the raw water 
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intake, in conjunction with coagulants, or in clarifiers in water treatment plants. It has been 
shown to inactivate certain organisms such as E. coli and poliovirus (US Environmental 
Protection Agency, 2012). This strong oxidant is easy to handle, is a readily soluble solid, and 
has a high efficiency in treating water and soil with a cost of $2.25 per pound for 98% material 
(2014 cost), depending on the quantity ordered. Figure 2.2 depicts the chemical structure of 
KMnO4. As of 2006 KMnO4 was not approved by the U.S. Food and Drug Administration as an 
aquaculture therapeutant (Hobbs, Grippo et al. 2006). 
 
Figure 2.2 Potassium Permanganate  
Hobbs, Grippo, Farris, Griffin, and Harding (2006) evaluated the acute toxicity of 
KMnO4 to non-target aquatic organisms to assess its exposure to aquatic life using acute toxicity 
testing. Previous research on the therapeutic use of KMnO4 as a disinfectant has not taken into 
account any toxicity to nontarget aquatic organisms. The toxicology, methodology, and 
evaluations used by Hobbs et al. (2006) contributes significantly to the evaluations of the 
controlled release chemical oxidant system for wastewater and natural water treatment in 
addition to chemical oxidant toxicity to D. magna and higher aquatic species.  Hobbs et al. 
(2006) conducted a static 96-h acute toxicity test where four non-target aquatic species of 
invertebrates and one species of fish (Ceriodaphnia dubio, Daphnia magna, Pimephales 
promelas, Hyalella Azteca, and Chironomus) were cultured and tested to evaluate the 
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environmental risks KMnO4 exposures has on non-target organisms. The test species used in this 
study represent a range of organisms that are typically found in freshwater ecosystems such as 
ponds. Test organisms were cultured according to standard U.S. Environmental Protection 
Agency procedures and survival data were recorded every 24-h.  
Four replicates were used per six treatments for each test ran in triplicate. All tests were 
conducted under a 16:8-h light:dark photoperiod and organisms were not fed during exposures. 
Two different types of water were used during this study using both moderately hard synthetic 
water and pond water. To determine whether pond water would have an ameliatory effect on 
KMnO4 toxicity, pond water was used. Water samples were collected and stock solutions were 
prepared using either water type, and serial dilutions were then made for the correlated exposure 
treatments at the nominal concentrations. Control test waters contained no KMnO4. Test 
solutions and then the organisms were added to the experimental chambers of test solution. 
Values for survival from toxicity were then collected and analyzed. This research study was 
necessary because there was limited data concerning KMnO4’s toxicity to non-target organisms 
in an aquaculture environment. 
Results of this study showed the majority of mortality occurred during the initial 48-h of 
the 96-h testing period. Hobbs et al. (2006) found that two species of Cladocerans,  D. magna 
and C. dubia were the most sensitive to aqueous KMnO4 for both synthetic and pond water 
exposures. Mean lethal concentration (LC50) values and standard deviation of 0.053 ± 0.009 mg 
L-1 for D. magna was found in hard water, and 1.98 ± 0.12 mg/L for the pond water was 
detected after the 96-h toxicity test. The value of D. magna’s LC50 was below the recommended 
KMnO4 treatment rate of at least 2.0 mg/L or 2.5 times the 15-minute water’s potassium 
permanganate demand (PPD). The PPD is the measure of the amount of organic matter and other 
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reducing agents present in the water. The PPD of the synthetic moderately hard water was 0.329 
± 0.114 mg/L and for pond water the PPD was 5.357 ± 0.967 mg/L. Although pond water offers 
an ameliorating effect on KMnO4, in order for the treatment to be effective, 2.5 times the PPD 
would have to be 0.823 and 13.392 mg/L KMnO4, respectively, which would exceed the LC50 
for most non-target organisms after treatment and showing that water column invertebrate 
herbivores are likely to be affected first. This may be due to KMnO4 ability to dissociate to the 
permanganate ion (MnO4-) once introduced to an aquatic system, a strong oxidizing agent, which 
is likely the reason for the rapid toxic effects. Ultimately, Hobbs et al. (2006) concluded that the 
test result from their study does represent an initial investigation into the possible effect that 
KMnO4 treatments may have on non-target aquatic organisms. 
More recently, few studies have evaluated the toxicity of KMnO4 to higher-level aquatic 
organisms. Darwish, Griffin, Straus, and Mitchell (2002) conducted a histological and 
hematological study on channel catfish Ictalurus punctatus to evluate the effect of KMnO4 
exposure. Three concentrations of KMnO4 were chosen to represent one, three, and five times 
the therapeutic concentrations (0.438, 1.315, and 2.190 mg/L, respectively), based on the 
KMnO4 demand, for 36-h.  and  discovered no mortalities in fish not exposed (control) or in fish 
exposed to the therapeutic dose of KMnO4. Mortalities were only observed in fish exposed to 
three and five times the therapeutic dose of KMnO4 (9.4% and 49.6%, respectively) with most of 
these mortalities occurring from exposure to 2-d postexposure. The result of these studies have 
shown that higher aquatic organisms’s exposure to KMnO4 produces minimal signs of stress 
when exposure is within the suggested therapeutic concentrations range. Cruz and Tamse (1986), 
Darwish et al. (2002), Griffin, Gollon, Hobbs, Kadlubar, and Brand (1999), and Griffin, Davis, 
Darwish, and Straus (2002) have shown that sublethal changes appear to be temporary and that 
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fish recover when returned to a KMnO4 free environment, implying that KMnO4 used as a 
waterborne disease therapeutant for channel catfish does not alter manganese content of edible 
muscle of channel catfish and should not present any hazard to human consumers. Furthermore, 
no changes were observed in any stress indicators measured suggesting that KMnO4 may be 
safely used as a disease therapeutant for channel catfish and other higher aquatic organisms. 
Zahran and Risha (2013) have also discovered that KMnO4 has proven to be a beneficial effect 
against certain fish diseases such as saprolegniosis and show a protective role against 
oxidative damage in saprolegniosis-infected Nile tilapia. Allowing water to break down further 
may be the next steps to observe D. magna’s mortality effects by using [A] – [A0] = -K* t; where 
the K value is the release of 0.0011g per day for KMnO4 treatment (Roger, 2012). 
2.6 Potassium Peroxymonosulfate 
Potassium peroxymonosulfate (KHS05 or Oxone®), a strong and highly water-soluble 
oxidant, is purposed with high oxidation potential and can be used in various particle treatment 
water applications (G. P. Anipsitakis, Tufano, & Dionysiou, 2008). Oxone® is a commercially 
patented chemical that is available through DuPont™. Oxone® provides powerful non-chlorine 
oxidation for a wide variety of industrial and consumer uses such as waste streams from mining 
operations and as a non-chlorine shock oxidizer for swimming pools and spas. Oxone® can also 
be used as an oxygen releasing agent in aquaculture and as a low temperature bleaching agent in 
detergent formulations (Sánchez-Fortún, Llorente, & Castaño, 2008).  
One of the major drawbacks of Oxone® treatment is the potential for ecological impacts 
following Oxone® release into receiving waters. The outcome of this occurrence results in acute 
toxicity from high concentrations of Oxone®, likely impacting river and lake areas. Due to 
Oxone® chemical characteristics, it is expected to dissociate into potassium (K+) and 
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peroxymonosulfate (SO5-) ions if released in natural waters (Sánchez-Fortún et al., 2008). 
Furthermore, the U.S. EPA has noted that peroxy compounds are known to be short-lived, with 
Oxone® half-life of 910 days (Durante & Bohn, 2007) due to their instability of the O-O bonds 
and are expected to degrade rapidly, Figure 2.2 (U. S. EPA, 1993). 
  
Figure 2.3 Potassium Peroxymonosulfate (Oxone®) 
Kennedy and Stock (1960) were among the first to investigate the reactions of a stable 
mixture of Oxone® with a variety of organic substances, as well as the utility of Oxone® in 
halogenation reactions. Rachlin & Perlmutter, 1968 were the first to suggest the in vitro use of 
fish cells for the assessment of the toxicity of environmental pollutants to aquatic biota. 
Observing the interactions between chemical contamination and biological systems with the use 
of in vitro cell cultures for ecotoxicological assessments can therefore be a valuable tool for an 
early and sensitive detection of chemical exposure (Sánchez-Fortún et al., 2008). Sanchez-Fortun 
et. al. (2008) used cytotoxicity testing to evaluate the toxic effects of Oxone® to determine if the 
compound would exhibit a risk to fish and other aquatic organisms after hull cleaning activities, 
leading to particles containing Oxone® entering the aquatic environment. The goal of that study 
was to also determine the effect of DNA damage induced by Oxone® used as an disinfectant in 
cooling towers, in RTG-2 cell line (Sánchez-Fortún et al., 2008).  
Cell lines have been used extensively to study the cytotoxicity of substances to fish cells 
(Bols, Dayeh, Lee, & Schirmer, 2005). Using a RTG-2 cell line, derived from rainbow trout 
gonadal tissue, two types of toxicity assays where performed. These two assays consisted of a 
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Neutral Red Assay and a DNA Denaturation Assay. The Neutral Red Assay included rainbow 
trout gonadal tissue cells that were seeded into a tissue culture plate. After a cell incubation 
period, cells were then incubated with Oxone® followed by replacement with neutral red 
solution. DNA denaturation assay included a 48-h cytotoxicity test performed to determine the 
desired range of concentration of Oxone® that resulted in loss of cell viability. DNA denaturation 
kinetics was performed with different serial dilutions of Oxone® with concentrations ranging 
from 5-500 mg/L, and double-stranded DNA percentages were calculated in relation to control; 
comparisons of untreated (control) and treated cells was then performed. 
Sanchez-Fortun et. al. (2008) found that the RTG-2 cell from rainbow trout gonadal 
tissue is sensitive to Oxone® chemical exposure, which has the ability to incur DNA denaturation 
and break DNA strands. However, no significant differences with respect to control were 
obtained when RTG-2 cell were exposed to Oxone® concentrations, obtaining a maximal strand 
scission factor (SSF) of 0.070. The median inhibition concentration (IC50) for Oxone® was 
101.11 mg/L and yield 95% confidence limit values 79.59 mg/L – 137.05 mg/L. Following 
exposure to Oxone®, induction of DNA damage concluded that after 30 min, less than 20% of 
DNA from control wells were denatured. Detecting small valued amounts of DNA is extremely 
important in a wide variety of biological applications. In further studies using established cell 
lines derived from bluegill sunfish (BF-2), rainbow trout gonads (RTG-2), and steelhead trout 
(STE), Castaño et al. (2003) evaluated the cytotoxicity of similar substances (Sánchez-Fortún et 
al., 2008), finding that higher aquatic organisms are affect by exposure.   
2.7 Controlled Release Biodegradable Polymer (CRBP) 
 Using biodegradable polymers to deliver chemical oxidants for agricultural and 
biomedical purposes have been proven effective (Akelah, 1996; Al-Zahrani, 1999). Akelah 
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(1996) shows that delivery of herbicides to plants at a controlled rate and in appropriate doses 
over a specified time has the ability to overcome serious environmental problems conventional 
herbicides present. In other works by Uhrich, Cannizzaro, Langer, and Shakesheff (1999) has 
determined that controlled release systems can be a carrier for drugs; improving efficiency, 
reducing toxicity, and improving patient compliance and convenience within delivery 
applications and in cases of placing non-toxic implants under the skin of humans. Notably, the 
CRBP is a solid at room temperature, soluble in water, chemically compatible with the oxidant 
of choice, and environmentally friendly (Kang et al., 2004).  
However, current literature shows that CRBP systems used for environmental purposes 
such as environmental protection, decontamination, and remediation continues to be a 
developing area within the body of environmental engineering. This facilitates the need to utilize 
CRBP to resolve environmental remediation and treatment of diseased water issues. There are 
several advantages to using a CRBP to treat contaminated water systems. Within this type of 
method, the oxidant remains stable when placed in a treatment system, it has the ability to reduce 
the amount of times infected waters may need treatment and it extends the release of the oxidant 
over a particular span of time. Figure 2.4 depicts the oxidant and polymer blend release system 
for oxidant discharge into water systems. First, the soluble polymer is placed in water and small 
pores are formed. The oxidant molecules then begin to diffuse with the water and disperse into 
the environment. Lastly, the oxidant is released and the polymer shell degrades naturally over 
time (S. Luster-Teasley et al., 2010).  
 
 
 
23 
 
Figure 2.4 Controlled release polymer design (S. Luster-Teasley et al., 2010) 
Following careful literature analysis and experimentation, S. Luster-Teasley et al. (2010), 
Luster-Teasley et al. (2009) and Rogers (2012 ) shows successfully developed encapsulated 
oxidants to create controlled release systems for remediation, in particular utilizing the chemical 
oxidants KMnO4 and Oxone®. KMnO4 and Oxone® were encapsulated inside the CRBP. The 
release of these oxidants in deionized water was then studied. In addition to release studies, the 
ability of Oxone® to treat contaminated water was also studied (Rogers, 2012). To prove this 
development was successful, stable, non-reactive and sustainable for extended longevity, 
KMnO4 was encapsulated and mounted on a glass slide. Photos at 40x and 100x were then taken 
of the CRBP using a digital microscope to observe any of these reactions along with signs of 
shell discoloration (Luster-Teasley et al., 2009). Figure 2.5 shows stable and non-reactive 
KMnO4 encapsulated in the CRBP. Figure 2.5a is a photo of the KMnO4 in the CRBP shell 
photographed on May 16, 2006 and Figure 2.5b shows the same sample on December 12, 2006 
(Luster-Teasley et al., 2009). 
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Figure 2.5 Photo of CRBP with KMnO4: (a) CRBP with oxidant at month zero and (b) CRBP 
with oxidant at month seven (Luster-Teasley et al., 2009).  
2.8 Toxicity of Controlled Release Biodegradable Polymer 
Biodegradable materials are natural or synthetic in origin and are degraded to produce 
biocompatible and toxicologically safe by-products (Makadia & Siegel, 2011). The area of 
environmental remediation is a continuous emerging area targeting controlled release uses 
known to lower toxicity of the CRBP and decrease risks associated with treatment. Makadia and 
Siegel (2011) found that some pellet fabrication systems are also open to the risk of denaturation 
of drugs during encapsulation.  
However, Rogers (2012) investigated this area and developed the appropriate procedure 
for a particular CRBP fabrication to lower the toxicity of the system and merit reasonability that 
toxicity remains low and environmental remediation remains highly effective. Rogers (2012) 
also investigated to the release rates of the CRBP developed in the Dr. Stephanie Luster-Teasley 
research group using the oxidants KMnO4 and Oxone® encapsulated within the CRBP shell. 
Through this study, Rogers (2012) determined a release rate of 0.0013 g per day over a 65 day 
period that was recorded for 0.1g KMnO4 encapsulated in 0.5g polymer. Also discovered was a 
release rate of 0.011 g per day over a 19 day period that was recorded for 0.3g Oxone® 
(a) (b) 
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encapsulated in 0.5g polymer. These findings provide valuable information to construct the ideal 
CRBP system to reduce toxicity and increase the amount of treatable water systems.  
Previous literature including (Craig, 2010), Rogers (2012), S. Luster-Teasley, Jackson, 
and Rogers (2011), Foster (2012), and McLeary (2013) investigated the production and use of 
the CRBP to treat natural surface water and wastewater from confined animal feeding operations 
(CAFOs). It was found that the CRBP technology was successful at reducing bacteria levels such 
as E. coli, Enterococci and Total Coliform and was also effective at treating for color and odor. 
Additionally, Taylor (2012) investigated the toxicity of treated wastewater and natural water to 
plants. Results showed that KMnO4 CRBP and Oxone® CRBP did not adversely effect Soy Bean 
Plants or Grasses for plant growth, height or appearance. Tissue cultures from a human lung 
carcinoma (A-549) cell line were also investigated to determine the toxicity of the CRBP and 
results showed that KMnO4 CRBP and Oxone® CRBP did not adversely effect human tissue 
cultures.  
2.9 US EPA WET Test 
According to the Clean Water Act Section 402, to maintain the chemical, physical and 
biological integrity of the nation’s water, the Whole Effluent Toxicity (WET) test is a vital 
component for improving water quality standards (U.S. EPA, 2000). The U.S. Environmental 
Protection Agency has declared Daphnia Magna (D. magna) a marker to determine whether 
diverse forms of chemical substances and mixture exposures are toxic to aquatic life within 
aquatic environments. The WET test will measure an organism’s response such as lethality, 
impaired growth, or reproduction upon exposure to the water sample. The WET test also enables 
us to replicate the total effect and actual environmental exposure of aquatic life to toxic 
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pollutants within wastewaters and natural waters without identifying the specific pollutants. This 
can be considered as one of the initial indicators for toxic water (EPA 2000).  
D. magna are primarily used for this type of bioassay because of their exceptionally 
sensitive behavior to chemicals and stressors in water. D. magna is derive from the Phyllopoda 
species, which is a form of freshwater crustacean that has been studied over the past 250 years 
(Ebert, 2005).  They are characterized by having leaf-like legs, and antennas which are used for 
swimming in various habitats of lakes, ponds, rocky pools, and other forms of natural waters 
found around the world. These locations include the northeastern U.S. Atlantic coastline, parts of 
Western Europe, and the Netherlands.  
D. magna are an important food source for fish and other bigger aquatic organisms. D. 
magna, also known as Cladoceran freshwater flea, are very small crustaceans consisting of an 
overall body shape of a kidney bean, bounded by a transparent shell-like structure, called a 
carapace, whose body length ranges from less than 0.5 mm to 5mm in size. An adult D. magna 
has the ability to release 4 to 10 eggs at a time within 38 hours. Although, it is not uncommon for 
adults to produce up to 20 eggs at a given time. The growth rate of the organism will vary due to 
many environmental factors such as temperature, pH, and food supply. Due to the transparency 
of its carapace, this species tends to reflect the color of what it is currently eating, also allowing 
for visible internal organs and easier recognition of organisms within culture. Males comprising 
of smaller size and larger antennas can distinguish female and male D. magna.  Figure 1 depicts 
the physical description of D. magna. The fact that these organisms are able to live in algal 
blooms, daphnia feed on algae and bacteria, where various studies show that they prefer algae as 
food (Keating, Caffrey, & Dagbusan, 1996). The benefits to using D. magna for this type of 
bioassay prove excellent organisms to test because they are extremely sensitive to changes in 
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water chemistry and they are simple and inexpensive to nurture in an aquarium. They mature in a 
matter of days, therefore, they do not take long to grow and become ready for testing. 
 
Figure 2.6 Anatomy of D. magna 
Therefore, in this thesis research, D. magna can be early indicators that there is a 
potential contamination in water, hence reducing the negative impact if concentrations of the 
chemical increase over time D. magna will aid in determining alternatives to delay the 
progression of contamination and increase avoidance to bacteria invading natural waters in 
addition to aiding in the reduction of bacteria exposed aquaculture environments. Using the 
controlled released biodegradable polymer, experimentation will occur to observe the survival 
and death in D. magna in different forms of impaired waters. This research is intended to serve 
as support for environmental toxicology, wastewater resources and environmental communities 
to provide data that can be used in determining the environmental impacts of KMnO4 and 
potassium Oxone® exposures to non-target organisms.  
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The purpose of this study was to evaluate the acute toxicity of KMnO4 and Oxone® to D. 
magna. The focus for this work is to determine the toxic effects on non-target organisms using 
the U.S. EPA approved Whole Effluent Toxicity (WET) Test performed with D. magna. 
Controlled Release Biodegradable Polymers (CRBP) were produced by encapsulating KMnO4 
and Oxone® in PCL per U.S. Patent #8,519,061. It was hypothesized that the CRBP could be a 
potential treatment technology to treat natural surface waters without toxicity to aquatic life. The 
research objectives for this study include: 
1. Trial I:  
(a) Toxicity of pure PCL to D. magna  
 (b) Toxicity of oxidants KMnO4 and Oxone® without encapsulation.  
2. Trial 2: Toxicity of oxidant encapsulation; KMnO4 CRBP and Oxone® CRBP  
3. Trial 3: a time-based experiment to see the toxicity of Oxone® CRBP to D. magna on 
an hour-by-hour basis.  
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 CHAPTER 3 
Methodology and Procedures 
The experiments for this research were developed to investigate a controlled release 
treatment that releases a chemical oxidant for an extended period of time. The goal was to 
determine if this method could be directly applied to treat impaired water.  Also to determine if 
use of controlled release polymers as a delivery system for oxidants can provide effective 
treatment at environmentally safe levels by exploring toxicological impacts, environmental 
impacts, and determining safe treatment levels for KMnO4 Controlled Release Biodegradable 
Polymers (CRBP) and Oxone® CRBP.  
3.1 Experimental Design  
D. magna (daphnia) used in this study were purchased from Carolina Biological Supply 
Company (Burlington, NC) and cultured in tanks of spring water under the hood at 68 - 72°C. 
The daphnia were fed Spriulina algae every 2 days or as needed. Acute toxicity tests were 
conducted with D. magna. D. magna were tested according to U.S. Environmental Protection 
Agency standards and procedures (US EPA, 2003). Data resulting in death, survival, and 
reproduction were recorded every 24 h. Randomly selected adult and juvenile test organisms 
from the stock daphnia tank were used for the experiments. Tests were conducted using bottled 
spring water and natural pond water impaired by community run-off.  
To investigate whether effluent water treated with the CRP systems containing either 
KMnO4 and Oxone® would adversely affect daphnia used as an indicator organism for toxicity, 
pond water was obtained from Country Park Lake located in Greensboro, N.C. and commercially 
available spring water was used as the test water. Country Park Late water was collected by 
using a telescopic environmental sampling pole shown in Figure 3.1. Water was then placed in 
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wide mouth sampling bottles, transferred in a cooler and stored within a refrigerated environment 
until use. 
   
Figure 3.1 (A) Sampling pole (B) sampling dip container (C) sampling bottle 
3.2 Controlled Release Biodegradable Polymer (CRBP) Formulation   
 The CRBP system is one of the focal points for all experiments performed in this study. 
CRBP was produced using an encapsulation method from Rogers (2012) and a modified method 
proposed in Kang et al. (2004). This thesis uses the same KMnO4 and Oxone® CRBP 
formulation as used in Rogers (2012). For CRBP, 0.5g PCL + 0.1g KMnO4 (KMnO4 CRBP) and 
0.5g of PCL + 0.3g Oxone®  (Oxone® CRBP) was blended and used for treatment. 
Table 3.1 
Chemical Blends and Concentrations Tested 
Chemical Blend Mass of Chemical (g) 
PCL 0.5 
KMnO4 0.1 
Oxone® 0.3 
 
(A) 
 
(B) (C) 
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CRBP were made by heating PCL at 90°C on a hotplate. KMnO4 was added to the molten PCL 
and mixed until completely blended together. Mixture was then removed from the hotplate. The 
polymer and oxidant mix was allowed to cool briefly and was rolled into a long, round solid coil, 
and cut into smaller pieces to achieve a pillow shaped pellet, shown in Figure 3.2. The 
formulation was then stored in a dry area. This process was repeated to prepare CRBP consisting 
of the Oxone®.  
 
Figure 3.2 KMnO4 and Oxone® CRBP pellets    
3.3 Stock Solution Preperation  
Stock solutions were prepared by using between 100ml  – 1000 L of either pond water or 
spring water with either pure KMnO4 or Oxone®, polymer or, CRBP pellets added to the water. 
Luster-Teasley et al. (2009) has shown that one batch of CRBP consiting of 0.3g Oxone® in 0.5g 
PCL can effectively remediate 200 – 500 ml of wastewater. This information provides details 
needed to understand the release portion of the CRBP over time that was used to remediate  test 
waters. Volumes of test waters ranging from 100 ml-1L of water were investigated for the 
studies. The CRBP pellets were allowed to release in the water for 24 hours. After 24 hours, the 
solution was then transferred into the experimental chambers. Figures 3.3 shows Country Park 
water along with KMnO4 and Oxone® CRBPs in pellet form release in to prepare stock solutions. 
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Figure 3.3 (A) KMnO4 CRBP release (B) Oxone® CRBP release  
3.4 D. magna Culture Preparation for WET Test 
According to the U.S. EPA, in order to determine the toxic effect of an environmental 
treatment, a Whole Effluent Toxicity (WET) test can be conducted to measure an organism’s 
response due to exposure (EPA, 2004). For this thesis, a static acute WET test was performed by 
exposing D. magna to various treatments for a period ranging from 3 days to 12 days. This was 
performed to assess the toxicity levels associated with the oxidants encapsulated in the CRBP 
and treated wastewater. D. magna were allowed to grow for at least three weeks in the stock 
daphnia tank before used for toxicity tests. This was to ensure that there would be a sufficient 
amount of test organisms without a shortage and that adult daphnia were used. Figure 3.4 depicts 
culture of D. magna in aquarium. 
 
Figure 3.4 Culture of D. magna 
(A) (B) 
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3.5 Acute Toxicity Test Procedure 
 For testing, 10 to 15 pill cups (experimental chambers) were used for each treatment. 
Crystal Geyser Natural Alpine Spring Water and Country Park water was used for stock 
solutions. Table 3.1 summarizes the solution concentrations, water type, and the length of each 
test. In Table 3.1, CRBP treatment blends consist of a control, PCL only and combinations of 
PCL with the selected polymer blend material that was placed in different volumes of water. 
CRBP was left to release in the water from a minimum of 24 hours to a maximum of 72 hours. 
After completion of time release, CRBP was removed from water to prevent further release. 
Water was used for D. magna experimental chambers. Test organisms were then transferred to 
chambers to begin testing.  
 
Figure 3.5 Trial I Experimental Design      
Treatments were labeled according to treatments and concentrations being tested and observed 
for a specified duration of time. Results were recorded every 24 hours and organisms were fed 
every other day. Statistical analysis was performed using GraphPad©  Prism Software, Inc. Any 
differences among treatments were analyzed by one-way Analysis of Variance (ANOVA), taking 
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p<0.05 as significant. Bonferroni’s multiple comparison tests were used as a posttest to further 
investigate significant values.  
Table 3.2 
Overview of Treatments and Concentrations for Trials I, II and III 
Treatment Water Type Test Volume (ml) 
Test Duration 
(d) 
Time Release 
(hr) 
Prep A: Untreated Control  Spring/CP 100-1000 3-12 − 
Prep B: 0.5g PCL  CP 100 3 24 
Prep C: 0.5g PCL + 0.1g KMnO4 Spring/CP 100-1000 3-12 24-72 
Prep D: 0.5g PCL + 0.3g Oxone® Spring/CP 100-1000 3-12 24-72 
*CP: Country Park Lake water  
3.6 Trial I: Toxicity of PCL and Pure Oxidants to D. magna 
D. magna were exposed to treated water to determine the toxicity of the CRBP. 
Treatments consisted of PCL and oxidant blends. In Table 3.2, for this experiment 0.5g PCL in 
pure form (no oxidant) was added directly to each pill cup. To begin this experiment a baseline 
concentration had to be performed to determine if the chemicals in pure form were toxic. This 
was a preliminary test to see if PCL polymer was toxic to D. magna and to see if oxidants 
without encapsulation will have an effect on the organisms. The hypothesis for the preliminary 
test was 0.5g PCL used for the CRBP would not be toxic to D. magna. Oxidants were added to 
100ml of CP water (see Table 3.3 for concentrations) for stock solution and were allowed to 
release for 24 hours. A pure CP water control was used. Forty pill cups in all were separated into 
four groups of ten, one set of ten for Prep A, one set of ten for Prep B, etc. With a pipette, 10ml 
of stock solution was added to each pill cup. Test organisms were then added. Treatments were 
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labeled as shown in Table 3.3 and observed for 3 days. Results were recorded every 24 hours and 
organisms were fed every other day. 
Table 3.3 
Labels for Trial I Treatments and Concentrations  
Treatment Water Type 
Test 
Volume 
(ml) 
Test 
Duration 
(d) 
Time  
Release 
(hr) 
Prep A: Untreated Control CP 100 3 − 
Prep B: 0.5g PCL  CP 100 3 24 
*Prep C: 0.5g PCL + 0.1g KMnO4 CP 100 3 24 
*Prep D: 0.5g PCL + 0.3gOxone® CP 100 3 24 
*Oxidants (KMnO4 and Oxone®) were not encapsulated to see impact of the full concentration. 
3.7 Trial II: Toxicity of Oxidant Encapsulation (CRBP) at Different Volumes and Release 
Times 
3.7.1 Toxicity of Oxone® CRBP in 300ml and 400ml. Testing D. magna toxicity 
against Oxone® CRBP was performed in a series of experiments. The CRBP was formulated 
according to procedures explained in section 3.2. Oxone® CRBP was added to 300ml and 400ml 
of CP water for stock solution and was allowed to release for 24 hours. A pure CP water control 
was used. This 24-hour period also allowed for the water to reach room temperature (approx. 
20°C) after being refrigerated. Sixty pill cups in all were separated into four groups of fifteen, 
two sets of fifteen for Prep A and two sets of fifteen for Prep B. With a pipette, 10ml of stock 
solution was added to each pill cup. Test organisms were then added. Treatments were labeled as 
shown in Table 3.4 and observed for 3 days. Results were recorded every 24 hours and 
organisms were fed every other day.  
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Table 3.4 
Labels for Treatments and Concentrations Tested for Oxone® Toxicity  
Treatment Water 
Type 
Test Volume 
(ml) 
Test Duration 
(d) 
Release Time 
(hr) 
Prep A: Untreated Control 
CP 300 3 − 
CP 400 3 − 
Prep B: Oxone® CRBP  
CP 300 3 24 
CP 400 3 24 
 
3.7.2 Toxicity of KMnO4 CRVP vs. Oxone® CRBP in 500ml. Testing to compare 
KMnO4 CRBP and Oxone® CRBP was done. The procedure for this experiment was identical to 
that in section 3.7.1 with the exception of increasing the water volume to 500ml. CRBPs were 
added to 500ml of CP water and allowed to release for 24 hours and come up to room 
temperature. A pure CP water control was used. Forty-five pill cups in all were separated into 
three groups of fifteen, one set of fifteen for Prep A, one set of fifteen for Prep B and one set for 
Prep C. With a pipette, 10ml sample stock solution was added to each pill cup. Test organisms 
were then added. Treatments were labeled as shown in Table 3.5 and observed for 2 days. 
Results were recorded every 24 hours and organisms were fed every other day. 
Table 3.5 
Labels for Treatments and Concentrations Tested with KMnO4 CRBP vs. Oxone® CRBP  
Treatment Water Type Test Volume (ml) 
Test Duration 
(d) 
Release Time 
(hr) 
Prep A: Untreated Control CP 500 2 − 
Prep B: KMnO4 CRBP  CP 500 2 24 
Prep C: Oxone® CRBP CP 500 2 24 
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3.7.3. Toxicity of KMnO4 CRBP vs. Oxone® CRBP in 600ml. Toxicity testing  
continued with increasing the water volume. The procedure for this experiment was identical to 
that reflected in section 3.7.1 with the expectation of using both spring water and CP water. 
Spring water was incorporated under the assumption that it may provide a better environment for 
test organisms and to observe if there will be a difference in results than from previous 
experiments. The water volume was increased to 600ml for each water type. After formulation, 
CRBPs were allowed to release in the water for 24 hours and reached room temperature. A pure 
spring water and pure CP water control was used. Prep A received pure spring water while Prep 
B received pure CP water. Sixty pill cups in all were separated into six groups of ten, two sets of 
ten for control’s A and B and four sets of ten for each treatment Prep C-Prep F. With a pipette, a 
10ml sample stock solution was taken from each treatment and placed into pill cups. Test 
organisms were then added. Treatments were labeled as shown in Table 3.6 and observed for 4 
days. Results were recorded every 24 hours and organisms were fed every other day. 
Table 3.6 
Labels for Treatments and Concentrations Tested with KMnO4 CRBP vs. Oxone® CRBP 
Treatment Water Type Test Volume (ml) 
Test Duration 
(d) 
Release Time 
(hr) 
Prep A: Untreated Control Spring 600 4 − 
Prep B: Untreated Control CP 600 4 − 
Prep C: KMnO4 CRBP Spring 600 4 24 
Prep D: Oxone® CRBP Spring 600 4 24 
Prep E: KMnO4 CRBP CP 600 4 24 
Prep F: Oxone® CRBP CP 600 4 24 
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3.7.4 Toxicity of KMnO4 CRBP vs. Oxone® CRBP in 700ml. The treatments used 
in this experiment were based on results from the previous experiment in Table 3.6. The volume 
of water was increased to 700ml. The goal was to compare the previous data with identical 
controls and treatments with a larger volume of water. After formulation of CRBPs as described 
in section 3.2, polymers were placed in waters and allowed to release for 24 hours. Water was 
allowed to reach room temperature during this time. Sixty pill cups in all were separated into six 
groups of ten, two sets of ten for control’s A and B and four sets of ten for each treatment. With 
a pipette, 10ml sample stock solution of each treatment and was taken added to each pill cup. 
Test organisms were then added. Treatments were labeled as shown in Table 3.7 and observed 
for 3 days. Results were recorded every 24 hours and organisms were fed every other day.  
Table 3.7 
Labels for Treatments and Concentrations Tested with KMnO4 CRBP vs. Oxone® CRBP  
Treatment Water Type Test Volume (ml) 
Test Duration 
(d) 
Release Time 
(h) 
Prep A: Untreated Control Spring 700 3 − 
Prep B: Untreated Control CP 700 3 − 
Prep C: KMnO4 CRBP Spring 700 3 24 
Prep D: Oxone® CRBP Spring 700 3 24 
Prep E: KMnO4 CRBP CP 700 3 24 
Prep F: Oxone® CRBP CP 700 3 24 
 
3.7.5 Toxicity of KMnO4 CRBP in 700ml after 24h, 48h, and 72h Release.   
Another toxicity test allowed the polymer to release for 24h, 48h and 72h in 700ml CP water. 
Table 3.8 lists the time frames the CRBPs were allowed to release. According to Table 3.8, each 
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polymer treatment was placed in 700ml CP water. The water was allowed to come up to room 
temperature. Depending on the time frame, the polymer was left to release with the water for 
24h, 48h or 78h and then the polymer was removed. The polymer was removed because any 
further reactions taking place between the water and the treatment were not desired. Ninety pill 
cups in all were separated into six groups of ten, three sets of ten for controls and three sets of 
ten for each treatment. With a pipette, a 10ml sample of stock solution was taken from the 24h, 
48h or 72h solution and was placed in each designated pill cup. Test organisms were then added. 
Treatments were labeled as shown in Table 3.8 and observed from 6-8 days. Results were 
recorded every 24 hours and organisms were fed every other day.  
Table 3.8 
Labels for Treatments and Concentrations Tested with KMnO4 CRBP: 24h, 48h, and 72h 
Release 
Treatment Water Type Test Volume (ml) 
Test Duration 
(d) 
Release Time 
(h) 
Prep A: Untreated Control CP 700 8 − 
Prep B: KMnO4 CRBP CP 700 8 24 
Prep C: Untreated Control CP 700 7 − 
Prep D: KMnO4 CRBP CP 700 7 48 
Prep E: Untreated Control  CP 700 6 − 
Prep F: KMnO4 CRBP CP 700 6 72 
 
3.7.6 Toxicity of KMnO4 CRBP vs. Oxone® CRBP in 700ml for 72h Release. The  
experiment was conducted similar to section 3.7.4 with the exception of CRBPs allowing to 
release for 72 hours as oppose to only 24 hours. To determine any toxicological effects that the 
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CRBP treatments might have on D. magna in 700ml of CP water, CRBP were formulated as 
described in section 3.2. According to Table 3.9, each polymer treatment was placed in 700ml 
CP water and was allowed to release for 72 hours. At this point water was also allowed to reach 
room temperature. After 72 hours, polymers were removed from water. Thirty pill cups in all 
were separated into three groups of ten; one set of ten for the control, one set of ten for treatment 
B and one set of ten for treatment C. With a pipette, a 10ml sample of stock solution was taken 
from the 72h release solution and placed in each pill cup. Test organisms were then added. 
Treatments were labeled as shown in Table 3.9 and observed from 6 days. Results were recorded 
every 24 hours and organisms were fed every other day. 
Table 3.9 
Labels for Treatments and Concentrations Tested with KMnO4 CRBP vs. Oxone® CRBP  
Treatment Water Type Test Volume 
(ml) 
Test Duration 
(d) 
Release Time 
(h) 
Prep A: Untreated Control  CP 700 6 − 
Prep B: KMnO4 CRBP CP 700 6 72 
Prep C: Oxone® CRBP CP 700 6 72 
 
3.7.7 Toxicity of KMnO4 CRBP in 800ml, 900ml and 1000ml. After conducting  
toxicity of KMnO4 CRBP vs. Oxone® CRBP in 700ml for 24 hours (section 3.7.5), increasing 
the concentrations to 800ml, 900ml and 1000ml was performed. This was done in order to 
investigate the outcome of D. magna toxicity with CRBPs and increased water volume. 
Similarly, after being formulated, each polymer treatment was placed in all three volumes of CP 
water and was allowed to release for 24 hours. Ninety pill cups in all were separated into six 
groups of fifteen; three sets of fifteen for the controls, three sets of fifteen for the treatments. 
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With a pipette, a 10ml sample of stock solution was taken from the 24h release solution and 
placed in each pill cup. This was done for every volume. Test organisms were then added. 
Treatments were labeled as shown in Table 3.10 and observed from 6-8 days. Results were 
recorded every 24 hours and organisms were fed every other day. 
Table 3.10 
Labels for Treatments and Concentrations Tested with KMnO4 CRBP 24h Release  
Treatment Water Type Test Volume (ml) 
Test Duration 
(d) 
Release Time 
(h) 
Prep A: Untreated Control CP 800 8 − 
Prep B: KMnO4 CRBP CP 800 8 24 
Prep C: Untreated Control CP 900 7 − 
Prep D: KMnO4 CRBP CP 900 7 24 
Prep E: Untreated Control  CP 1000 6 − 
Prep F: KMnO4 CRBP CP 1000 6 24 
 
3.8 Trial III: A Time-Based Experiment 
Given the results from the toxicity to D. magna in previous experiments, a time-based 
toxicity test was performed. The test would track the treated water affects each hour. 700ml of 
CP water was used prepared. The CRBP was formulated identical to previous experiments. The 
polymer was left to release in water for 24h, and then it was removed. Fifty pill cups in all were 
used to shown in Figure 3.5. With a pipette, a 10ml of sample stock solution was added to each 
pill cup. Test organisms were then added. Data was recorded every hour from the time the first 
organism was placed inside the chambers. Data was collected until there was no sign of survival.  
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Table 3.11 
Label for Treatment and Concentration Tested for Time-Based Experiment 
Treatment Water Type Test Volume (ml) Test Duration (h) 
Oxone® CRBP CP 700 3 
 
3.9 Statistics  
 Statistical analysis was performed using GraphPad© Prism Software, Inc. Differences 
among treatments were analyzed by one-way analysis of variance (ANOVA), taking p<0.05 as 
significant and two-way ANOVA, taking p<0.01 as significant. Bonferroni’s multiple 
comparison tests were used as a post-test to further investigate significant values. One-way 
ANOVA for KMnO4 was performed to observe a significant difference between the controls and 
treatments throughout this study. Trial 1 (a) and (b) used one-way ANOVA taking p<0.05 as 
significant to compare the control 0.5g PCL + 0.1g KMnO4 and the control verses 0.5g PCL + 
0.3g Oxone®. Trial II toxicity used the one-way ANOVA to compare; (1) KMnO4 CRBP verses 
Oxone® CRBP in 700ml CP water after 24h release compared the (2) control verses Oxone® 
CRBP, (3) Oxone® CRBP in spring water verses KMnO4 CRBP in CP water and (4) KMnO4 
CRBP in CP water vs. Oxone® CRBP in CP water. Trial II continues to use the one-way 
ANOVA to compare the toxicity of KMnO4 CRBP vs. Oxone® CRBP in 700ml of CP after 72h 
release compared (1) KMnO4 CRBP vs. Oxone® CRBP. A Two-Way ANOVA for KMnO4 
CRBP to note a significant difference between 24h, 48h and 72h release. A comparison between 
24h vs. 48h release of the KMnO4 CRBP and 24h vs. 72h release of KMnO4 CRBP was 
conducted using p value<0.01 for the two-way AVOVA.  
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 CHAPTER 4 
Results and Discussion 
4.1 Controlled Release Experiments Using CRBP 
The study of KMnO4 CRBP and Oxone® CRBP released over time and exposed to D. 
magna was investigated. It was hypothesized that the CRBP could be a potential treatment 
technology to treat natural surface waters without toxicity to aquatic life. The oxidants were 
encapsulated inside PCL and placed in 100ml-1000ml of spring water or CP water. Figure 4.1 
shows an example of the oxidants diffusing from the polymer after they were placed in water. 
For this thesis, experiments were divided into three trials. Trial I was performed to show (a) the 
toxicity of pure PCL to D. magna and (b) to show the toxicity of oxidants without encapsulation. 
In Trail II, all experiments conducted were to show toxicity of oxidant encapsulation, KMnO4 
CRBP and Oxone® CRBP when exposed to D. magna at different volumes and released over 
different time frames. Finally, Trail III shows a time-based experiment to see the toxicity of 
Oxone® CRBP to D. magna on an hour-by-hour basis. Raw data for the experiments is available 
in the Appendix. 
 
 
 
 
 
 
44 
 
Figure 4.1 Initial release of (A) KMnO4 CRBP and (B) Oxone® CRBP Released in Water 
4.2 Toxicity of CRBP to D. magna 
D. magna is the most commonly used non-target aquatic species used in toxicology tests. 
They are used for a wide range of purposes including assays for pure materials and complex 
industrial discharges. The data obtained in literature often suggests that D. magna are among the 
most sensitive aquatic organisms tested. Therefore, the results in these experiments will be used 
to determine safe concentration levels of CRBPs for the treatment of contaminated or impaired 
water systems. In these experiments, the number of mobile D. magna was recorded at the end of 
every 24h period. D. magna that did not move within 15 seconds, following a gentle agitation of 
the pill cup, were considered immobilized or dead.  
4.3 Trial I 
4.3.1 Trial I (a) D. magna exposure to 0.5g PCL in CP water. PCL and oxidants  
including KMnO4 and Oxone® in pure form were released for 24h in separate beakers, each 
containing 100ml of CP water. Oxidants were not encapsulated in order to see the impact of the 
full concentration. Concentration amounts previously mentioned in chapter 3, Table 3.2 were 
measured using a laboratory scale. Figure 4.2 shows 0.5g PCL compared to the control 
indicating more than 90% survival. The PCL material itself does not appear to be toxic to D. 
(A) (B) 
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magna in the lowest volume (100ml) of water tested. Statistical analysis confirms this result 
showing no difference between the control and the PCL as seen in Table 4.1. These findings 
confirm PCL would not pose a potential threat in aquatic systems as the stabilizing material for 
oxidant encapsulation. 
 
Figure 4.2 Impact of 0.5g PCL and pure oxidants KMnO4 and Oxone®   
4.3.2 Trial I (b) D. magna exposure to oxidants without encapsulation. In addition 
 to preliminary experiments with PCL, the oxidants KMnO4 and Oxone®, in pure form, were 
exposed to D. magna. The data indicated in Figure 4.2 shows that 99.9% of D. magna treated 
with pure KMnO4 and Oxone® in 100ml of control waters died after day 0. With respect to the 
control, there is a significant difference between both oxidant treatments (Table 4.1). Increased 
toxicity was observed in the samples without encapsulation with the potential to kill aquatic 
organisms within a water body being treated by Oxone®. 
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Table 4.1 
Bonferroni’s Multiple Comparison Results for D. magna Exposed to Trial I  
Treatment 
Mean 
Diff. 
Significant? 
P < 0.05? 
Summary 
95% CI of 
diff. 
Control vs. 0.5g PCL 2.167 No ns -6.342 to 10.68 
Control vs. 0.5g PCL + 0.1g 
KMnO4 
9.167 Yes * 0.6582 to 17.68 
Control vs. 0.5g PCL + 0.3g 
Oxone® 
9.583 Yes * 1.075 to 18.09 
 
The potential toxicity of KMnO4 compound recorded by Hobbs et al. (2006) solidifies the results 
achieved in KMnO4 experiment. KMnO4 (without encapsulation) in Hobbs et al. (2006) was 
identified as having a high degree of toxicity to fish, which are classified as a higher aquatic 
organism than D. magna. KMnO4, due to its strong oxidant nature, caused damage to delicate 
tissues like skin and gills in fish. The degree of damage to tissues was dependent upon the 
KMnO4 concentration (Darwish et al. 2002). Similarly, França et al. (2001) reported that the 
toxicity of KMnO4 performed with the microcrustacean cladoceran C. dubia, which is a species 
similar to D. magna. Acute toxicity occurred after 24 hours of exposure with KMnO4 
concentrations of 0.25 mg/L of KMnO4.  
4.4 Trail II  
All experiments conducted in Trial II were to show toxicity of oxidant encapsulation, 
KMnO4 CRBP and Oxone® CRBP when D. magna are exposed at different volumes and varying 
exposure times.   High mortality rates occurred with Oxone® CRBP treated water within 24h. 
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When compared to Oxone® CRBP, KMnO4 CRBP exposures appeared to have better survival 
rates. Trial II experiments will show these results.  
4.4.1 Toxicity of Oxone® CRBP 24 hour release in 300ml CP water. Test organisms  
were exposed to Oxone® CRBP after it was released in 300ml of CP water for 24h. Figure 4.3 
shows the impact of Oxone® CRBP to D. magna over a 2 day period. When comparing the 
control to the Oxone® treatment, it is evident that the survival rates are extremely different. 
While the control appears to have remained constant throughout the duration of testing, 100% of 
D. magna exposed to Oxone® CRBP died after day 0. Further experimentation will identify the 
cause of rapid and excessive mortality rates of D. magna in an Oxone® CRBP environment.  
 
Figure 4.3 Impact of Oxone® in 300ml CP water 24h release 
4.4.2 Toxicity of KMnO4 CRBP vs. Oxone® CRBP 24h release in 500ml CP water.  
To further investigate the outcome of toxicity testing performed in Figure 4.3. CP water was 
increased in volume from 300ml to 500ml. It was hypothesized that D. magna survival would 
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increase in a larger volume of water containing the Oxone® CRBP. As shown in Figure 4.4, the 
impact of the Oxone® CRBP once again resulted in 100% mortality (n = 64).  
Figure 4.4 Impact of KMnO4 CRBP vs. Oxone® CRBP in 500ml CP water 24h release 
The controls began to die as seen in Figure 4.5. The control and KMnO4 treatment 
relationship is very close on day 1, going from n=44 D. magna in the control to n=15. For the 
KMnO4, the initial n=57 decreased to n=16. These results led to question if there were problems 
with toxicity of the CP water more than the oxidant. Perhaps the samples of CP water collected 
contained chemicals or substances that were not conducive to D. magna. Country Park Lake does 
not currently have a population of D. magna growing in the water but does have higher-level fish 
that are added to the lake for public fishing and recreational purposes. Country Park Lake 
receives water from a number of sources from the watershed including run-off, groundwater 
from a nearby park, neighborhoods, or surrounding industrial areas that could impair the 
waterway. 
In support of this claim, the City of Greensboro reported the 2012 Water Quality Results 
Monitored Leaving The Treatment Plant table that summarized a number of contaminants and 
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their potential sources found in Greensboro lakes. Manganese, induced by landfill and cropland 
runoff as well as deposits occurring naturally was found. Synthetic organic chemicals such as 
pesticide and herbicide runoff and discharge from rubber & chemical factories were also 
indicated, and total trihalomethanes (TTHM) by-products of drinking water disinfection was 
recorded. The report notes that some people who drink water containing trihalomethanes in 
excess of the MCL (the highest level of a contaminant that is allowed in drinking water) over 
many years may experience problems with their liver, kidneys, or central nervous systems, and 
may have an increased risk of getting cancer. (City of Greensboro, 2012). Since D. magna are 
not found in Country Park surface water, chemicals and substances in the CP water could have 
been present in water samples leading to high D. magna mortality.  
Table 4.4 shows comparisons between treatments and controls. The relationships indicate 
no significant difference, sharing comparable probabilities that more than 80% of the population 
will die. In assessing the importance of this result, it is the size of the effect not just the size of 
the significance that matters. The size of the effect related to Oxone® CRBP and CP water is 
significant and the observed data is consistent throughout testing with as much as 90% mortality 
after 24h in these exposure.  
Table 4.2 
Bonferroni's Multiple Comparison Test Results of CRBPs release in 5ooml CP water    
Treatment Mean 
Diff. 
Significant? 
P < 0.05? 
Summary 95% CI of diff 
Control vs. KMnO4 CRBP:  0 No ns -75.73 to 75.73 
Control vs. Oxone® CRBP:  5.333 No ns -70.40 to 81.06 
KMnO4 CRBP vs. Oxone® CRBP  5.333 No ns -70.40 to 81.06 
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4.4.3 Toxicity of KMnO4 CRBP vs. Oxone® CRBP 24h release in 600ml CP water. 
As seen in Figure 4.4, perhaps sample CP water used in Figure 4.5 contained similar substances 
that caused significant mortality since the same sample water was used in both experiments. 
Figure 4.5 depicts D. magna experiencing 100% mortality in three out of four treatments which 
included KMnO4 CRBP in spring water, Oxone® CRBP in spring water, and Oxone® CRBP in 
CP water. The two Oxone® CRBP treatments had 100% mortality after day 0. Controls also 
show declining D. magna survival decreasing from n=10 in the spring water control to n=0 and 
from n=12 in the CP water control to n=3 after 4 days of exposure. Since this is a static, non-
renewal toxicity test, the test organisms are exposed to the same test water for the duration. 
Therefore, the belief was that CP water could be the reason for more than 50% mortality in the 
CP water control after day 3.  
Figure 4.5 Impact of KMnO4 CRBP vs. Oxone® CRBP in 600ml CP water 24h release 
However, it is possible to incorporate additional information that will aid in the interpretation of 
test results. Therefore, spring water was incorporated as an additional water type used in the 
experiments to confirm this assumption. The spring water control did not perform as well when 
 
 
 
51 
compared to the CP water control. Figure 4.5 also shows all treatments containing Oxone® 
CRBP and/or spring water had an immediate negative effect on D. magna survival with more 
than 50% mortality. Because the Oxone® CRBP exhibits identical behavior in spring water and 
in CP water, this suggests that chemical effects may be a contributor to 100% D. magna 
mortality. The chemical structure of the oxidant makes it highly capable of inducing DNA 
damage or producing binds to single-stranded DNA, causing strand scission in specific areas of a 
guanine site (Sánchez-Fortún et al. 2008). This supports the outcome in this study, suggesting 
DNA denaturation is the source of mortality in non-target organisms when exposed to 
strengthened oxidants such as Oxone®. KMnO4 CRBP in CP water seemed to perform better than 
any other treatment with slight decline in survival over a 4 day period. 
4.4.4 Toxicity of KMnO4 CRBP vs. Oxone® CRBP 24h release in 700ml CP water.  
In figure 4.6, Oxone® CRBP again showed high toxicity with 100% mortality observed within 
the first 24h. Since the reason for mortality has been assessed in the previous experiment (4.4.3), 
looking at the Oxone® CRBP releasing for a longer period of time to achieve higher mortality 
rates will follow. In treatments with KMnO4 CRBP in spring water, high mortality rates were 
recorded with n=17 at day 0 to n=1 at the end of day 1 exposure. This confirms that spring water 
does not provide a desired environment for D. magna as seen in previous experiments. This 
could be due to spring water lacking the natural components that appear in an environment 
where D. magna are found.  In addition, Figure 4.6 shows small changes in D. magna recovery 
in KMnO4 spring water were noted at day 1 with n=5 by the end of testing. Hobbs et al. (2006) 
observed similar results after a static 96h pure KMnO4 exposure to species of fish.  
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Figure 4.6 Impact of KMnO4 CRBP vs. Oxone® CRBP in 700ml CP water 24h release 
When comparing between KMnO4 CRBP in spring water and KMnO4 CRBP in CP water, there 
is a significant difference.  Surprising, the CP water control remains constant throughout the 
duration of this experiment. Although this is the same sample CP water that was used in previous 
experiments, it appears to becoming a suitable environment with almost a 40% increase in D. 
magna survival and experiencing reproduction within the initial 24h exposure period.  
4.4.5 Toxicity of KMnO4 CRBP 24h, 48h and 72h release in 700ml CP water.  
Results gained from Figure 4.6, where a slight increase in KMnO4 exposed D. magna survival 
begins to occur led to the curiosity of what would happen if the KMnO4 CRPB was allowed to 
release for longer periods of time. Figure 4.7 shows KMnO4 CRBP in 700ml of CP water for 
24h, 48h and 72h, respectively. During the exposure period n=10 for CP water control going to 
n= 10 and n=10 for KMnO4 CRBP in CP water to n=1 after 8 days of exposure. Figure 4.7 I. 
shows CP water control and 24h release of KMnO4 CRBP are similar from day 1-3, but after day 
3, the KMnO4 treatment began to die faster.  
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Figure 4.7 Impact of KMnO4 CRBP vs. Oxone® CRBP in 700ml CP water 24h-78h  
According to (Francis-Floyd & Klinger, 2009), KMnO4 is an oxidizing agent capable of 
reacting with any organic material present in the water, including bacteria, fungi and other 
parasites. This can cause substances that are easily oxidized to rapidly decrease the activity of 
KMnO4 and this initial demand on the compound decreases its effective concentration (Franca et 
I. II. 
III. 
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al 2011). Figure 4.8 is a photo of the watercolor change from pink to brown due to the formation 
of manganese dioxide (MnO2). MnO2 is a product of the reduction of KMnO4 (Franca et al. 
2011). Therefore, this explains the high mortality rates achieved in previous experiments. As 
seen in Figure 4.6 and Figure 4.7 (I), the first hours of the experiment, the small amount of 
organic matter present had little effect on KMnO4 toxicity, which explains the high mortality rate 
in the initial period of 24h exposure (Franca et al. 2011). 
 
  
Figure 4.8 Change in water color (A) initial KMnO4 (B) KMnO4 CRBP after 24h release 
 Compared to Figure 4.7 I, Figure 4.7 II and Figure 4.7 III show improvement in D. magna 
survival and reproduction rates when the release time is extended from 24h to 48h and 72h. In 
Figure 4.7 II and Figure 4.7 III, the KMnO4 CRBP mimics the CP water control, which is a 
desirable effect. Figure 4.7 II (48h release) and Figure 4.7 III (72h release) behaviors suggest 
neither the water nor the CRBP negatively impacts the organisms with n=37 for CP increasing to 
n=75 by day 7 due to reproduction of the D. magna during the experiment. For KMnO4 CRBP in 
CP water starting with n=32 D. magna increased to for to n=61 by day 7. This is almost a 30% 
increase in survival when the KMnO4 CRBP release when the 48h survival and reproduction 
(A) (B) 
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rates are compared to the 24h survival and reproduction rates. Reproduction is an important 
outcome because D. magna reproduction has an impact on population of the organism and food 
web dynamics in aquatic systems. In Figure 4.7 III D. magna behaviors also demonstration 
positive results with n=23 for CP water control at day 0 to n=59 by day 7 and n=25 for KMnO4 
CRBP in CP water to n=82. This exhibits almost a 60% increase in survival when KMnO4 CRBP 
release occurs for 72h compared to 48h and 24h. KMnO4 treatments appear to perform better 
when CRBP is allowed to release for longer periods of time before being exposed to organisms. 
Both KMnO4 CRBP treatments after 48h and 72h release followed the same trend as the 
untreated CP water control by producing offspring that mimic the reproduction of the control. 
This suggests that KMnO4 CRBP is not harmful to non-target aquatic organisms if the treated 
water is held for 48h or 72h before being released into the environment. Figure 4.9 shows a Two-
Way ANOVA conducted to perform a dose and time effect study of 24h, 48h and 72h release of 
KMnO4 CRBP in CP water. This experiment confirmed if extended release time frames of the 
CRBP would yield higher D. magna survival, increased reproduction, and effective remedial 
treatment. 
Figure 4.9 Two-Way ANOVA for KMnO4 CRBP Toxicity for 24h, 48h, and 72h Release 
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 In Hobbs et al. (2006), used 5-10 organisms for their study whereas for this thesis 
research used 10-20 organisms. Both this thesis and Hobbs et al. (2006) used D. magna and the 
same statistical model with the one-way ANOVA for statistical analysis.  Both studies used 
KMnO4 performed used similar organisms, and the same statistical model with one-way 
ANOVA statistical analysis to notes significant differences between treatments. The two studies 
were performed also used KMnO4. Hobbs et. al (2006) and this studied 3-day acute toxicity 
testing whereas this study observed 6-8 day acute toxicity testing. Similar findings were obtained 
between the two studies for KMnO4. A significant difference between this study and Hobbs et al. 
(2006) shows that KMnO4 left treated at an extended period of time will result in greater D. 
magna survival as well as increased reproduction. Hobbs et al. (2006), however, did not observe 
reproduction occurrences.  
4.4.6 Toxicity of Oxone® CRBP 72h release in 700ml CP water and Toxicity of 
KMnO4 CRBP vs. Oxone® CRBP 72h release in 700ml CP water. The toxicity of KMnO4 
CRBP versus Oxone® CRBP 24h release in 700ml CP water is presented in Figure 4.11 (A). This 
figure shows Oxone® CRBP released for 72h to determine if the retention time of 72 H would 
improve D. magna survival. In Figure 4.10 (B) when comparing KMnO4 CRBP in CP water to 
Oxone® CRBP in CP water, there is a significant difference also shown in Table 4.7. KMnO4 
CRBP is 100% more likely to have better survival results. As seen in previous experiments in 
this study, Oxone® continues to exhibit 100% mortality regardless of the volume of water used. 
In Figure 4.10 (B), Oxone® CRBP also proves that it will exhibit 100% mortality regardless of 
the release time. This suggests this form of treatment should not be exposed in water systems 
where aquatic life is present. In Figure 4.10 (B), by day 5, more than a 50% increase in D. magna 
survival is seen within KMnO4 CRBP treatment compared to 0% survival for Oxone® CRBP 
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treatment. This is a viable form of treatment and with increased release time periods present 
minimal effects to non-target organisms.  
 
  
Figure 4.10 The impact of Oxone® CRBP in 700ml CP water after 72h 
Table 4.3  
Bonferroni's Multiple Comparison Test Results for CRBPs 72h Release in 700ml water 
Treatment Mean Diff. 
Significant? 
P < 0.05 Summary 95% CI of diff 
Control: CP vs. KMnO4 CRBP -4.2 No ns -16.78 to 8.381 
Control: CP vs. Control: CP 1 No ns -11.58 to 13.58 
Control: CP vs. Oxone® CRBP: CP 12.2 No ns -0.3812 to 24.78 
KMnO4 CRBP: CP vs. Control: CP 5.2 No ns -7.381 to 17.78 
KMnO4 CRBP: CP vs. Oxone® 
CRBP: CP 
16.4 Yes ** 3.819 to 28.98 
Control: CP vs. Oxone® CRBP: CP 11.2 No ns -1.381 to 23.78 
(A) (B) 
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4.4.7 Toxicity of KMnO4 CRBP vs. Oxone® CRBP 24h release in 800ml, 900ml and 
1000ml CP water. Figure 4.11 shows KMnO4 release for 24h in 800ml, 900ml and 1000ml. 
This was done to see if increasing the volume of water would make a difference in D. magna 
survival. Figure 4.11 I. and II. appear similar from 0-7 days. When culturing D. magna, test 
organisms have to become acclimated to the new environment. Figure 4.11 I and II show 
KMnO4 mimicking the CP water control until day 8, after which the control exhibits extremely 
high rates of reproduction. Despite this increase, the KMnO4 trend line stays relatively constant. 
Testing 800ml, 900ml and 1000ml CP water with KMnO4 CRBP took place at the same time. 
For this reason, questions arise when comparing Figure 4.11 I and II with Figure 4.11 III. The 
later results show various factors that could be the reason why the treatment that caused 
unexpected results.  
It is not always possible to identify any particular isolated test outcome at the conclusion 
of an experiment due to a number of potential factors, both known or unknown, that could 
impact the results (EPA, 2000). For example, quality assurance (QA) information can be used to 
assess the overall quality of the test system (i.e. test facility, culture procedures, test 
maintenance, skill of the researcher, etc.). Small significant effects may be more difficult to 
verify hence the need for follow-up testing. 
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Figure 4.11 Impact of KMnO4 CRBP vs. Oxone® CRBP in 800ml, 900ml and 1000ml CP water 
  
I. II. 
III. 
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4.4.8 Toxicity of Oxone® CRBP 24h release in 700ml CP water. Oxone® CRBP was  
investigated to determine the cause of high mortality when exposed to D. magna. Previous 
studies concluded that Oxone® encapsulated CRBP should release at a rate of 0.011 grams per 
day (Rogers, 2012). For a time-based study, Oxone® CRBP was released in 700ml of CP water 
for 24h. Figure 4.12 presents the toxicity of Oxone® to D. magna. A large sample size (n=59) of 
test organisms was used to demonstrate the strength of Oxone®.  As shown in Figure 4.12, within 
a 3h period of time all test organisms died (100% mortality).  
Figure 4.12 Impact of Oxone® CRBP in 700ml CP water hour-by-hour 
Within the 3h exposure period, D. magna went through three phases before reaching 
100% mortality. In the first phase, sporadic swimming and increased escape maneuvers were 
observed. In the second phase, movement became less continuous and began to slow down 
throughout the testing period. In the third phase, D. magna exhibited lightening in color, almost 
becoming white, and began to undergo a bleaching effect. Sánchez-Fortún et al. 2008 soldifies 
the reults obtained in this experiment by discovering that when RTG-2 cells derived from 
rainbow trout were exposed to Oxone®, DNA from control cells were denatured after 30 minutes. 
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The authors also found that with respect to Oxone® assays, any concentration used exhibited a 
statistical different response with respect to DNA denaturation control curves. Similarly, Ross 
and Burrows (1996) studied bromination of cytosine and the formation of a piperidinelabile site 
using simple salts such as Oxone®. They observed that when Oxone® was allowed to react with 
single-stranded oligodeoxynucleotides, a simple cytosine-specific reaction utilizing Oxone® lead 
to scission of single-stranded DNA after piperidine treatment. This solely confirms that Oxone® 
oxidants or Oxone® CRBP should not be used directly in water systems where aquatic life is 
present.   
 
 
Figure 4.13 The impact of Oxone® CRBP in 700ml CP water hour-by-hour 
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 CHAPTER 5 
Conclusion and Future Research 
The KMnO4 CRBP and Oxone® CRBP toxicity test using D. magna represents an initial 
investigation into the possible toxic effects of KMnO4 and Oxone® treatment within an 
encapsulated biodegradable polymer structure. The Whole Effluent Toxicity (WET) test 
demonstrated that as the CRBP exposure time increased, the toxic effects to non-target aquatic 
organisms were observed to decrease for KMnO4 CRBP. PCL appeared not to be toxic to D. 
magna and confirming encapsulation of oxidants within this structure has the potential to reduce 
oxidants’ potential toxic effects. The WET test also suggested that the Oxone® CRBP hindered 
D. magna growth in natural waters. Oxone® in this study consistently led to death of the test 
organisms, which is consistent with the results from Sanchez-Fortun et al. (2008) where Oxone® 
caused DNA damage to test organisms. The Oxone® CRBP resulted in 100% mortality in 
volumes ranging from 100ml to 1000ml of test waters and up to a 72h release time periods. The 
result obtained from this study provides evidence that Oxone® is not suitable for natural waters 
which may contain aquatic life and freshly treated water with Oxone® should not be released 
directly into the environment. Oxone® CRBP treatment would be more suitable as a contained or 
controlled industrial water or wastewater treatment process. Examples that would be feasible for 
Oxone® CRBP include wastewater treatment facilities, swine farms, environmental treatment 
facilities, lagoons, or any water system environment where no aquatic life will directly receive 
treated effluent water earlier than a 48 hour retention time. 
KMnO4 CRBP exhibited signs that the oxidant treatment, when encapsulated, does not 
significantly alter the survival or reproduction of D. magna. KMnO4 CRBP treated water, 
demonstrated minimum impact on D. magna based on treatment volume and retention time for 
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48 to 72 hours. KMnO4 CRBP released in Country Park water demonstrated the best survival 
when compared to the control out of all the treatments in 700ml to 1000ml volumes from 48h to 
72h CRBP release time period. Undesirable results observed at lower water volume levels and at 
shorter release times may have been attributed to a relativity high initial release rate of the 
KMnO4 from the polymer structure. In the case of KMnO4, manganese dioxide formation of 
KMnO4 in aqueous solution decreased D. magna survival. The results of this work can help to 
determine which water treatment system would be best for aquatic life using either KMnO4 
CRBP or Oxone® CRBP to treat contaminated water systems.  
In this study, surface water collected from Country Park Lake in Greensboro, NC offered 
better testing source water for the research study. Data obtained from this thesis may be used in 
future research to further study the potential effects of the technology on non-target organisms. 
The CRBP technology serves as a potential method to treat water, provided the limitations for 
the oxidants are considered. For example, KMnO4 will turn treated waters purple whereas 
Oxone® has high oxidation strength. Although the formation of manganese dioxide when 
KMnO4 is in aqueous solution is produced, this positive chemical reaction has the ability to turn 
the water from a purple or pink color to a more brown color, which will possibly appear normal 
when released in treated waters. Oxone®, as a treatment method, should be used in a controlled 
system and waters should be contained and not released directly into surface water; however, 
treated water can be applied for irrigation or water reuse on-site. 
Further research is needed to: (1) Determine toxicity of Oxone® within wastewater 
systems; (2) determine the amount of CRBP to use for a particular size water body that requires 
treatment; (3) conduct more time based experiments using Oxone® CRBP at 48h and 72h time 
frames to see what happens on a time scale; and (4) conduct additional toxicity tests at different 
 
 
 
64 
CRBP release time frames in different volumes of test waters. The data obtained in this study 
should be used to test bacteria levels that would remain exposed for 24h in 800ml, 900ml, 
1000ml and higher of CP water and measure how much E coli and enterococci remains after 7 or 
8 days; and determine if the type of test water, depending on bacteria present, will affect the 
predetermined release rate of the CRBP.   
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Appendix 
Table A.1 
D. magna Survival (n) for Trial I (a) & (b)  
 24h Treatment 
Day Control: CP 0.036g PCL 0.5g PCL + 0.1g KMnO4 
0.5g PCL + 0.3g 
Oxone® 
0 10 10 10 11 10 10 10 11 10 10 10 10 
1 13 8 10 11 10 10 0 0 2 0 0 0 
2 15 10 10 11 10 8 0 0 1 0 0 0 
3 23 15 11 10 10 8 0 0 1 0 0 0 
 
 
Table A.2 
Oxone® CRBP Impact to D. magna (n) in 300ml CP water for 24h  
24h Treatment 
Day Control Oxone® CRBP: CP Water 
0 35 35 26 35 35 28 
1 35 35 25 0 0 0 
2 33 32 20 0 0 0 
 
 
Table A.3 
KMnO4 CRBP vs. Oxone® CRBP Impact to D. magna (n) in 500ml CP water for 24h 
24h Treatment 
Day Control: CP 
n 
KMnO4 CRBP: CP 
n 
Oxone® CRBP: CP 
n 
0 44 57 64 
1 15 16 0 
2 18 7 0 
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Table A.4 
KMnO4 CRBP vs. Oxone® CRBP Impact to D. magna (n) in 700ml CP water for 24h 
24h Treatment  
Day Control: Spring 
Control: 
CP 
KMnO4 
CRBP: 
Spring 
Oxone® 
CRBP: 
Spring 
KMnO4 
CRBP: 
CP 
Oxone® 
CRBP: 
CP 
0 13 17 17 12 15 14 
1 11 13 1 0 21 0 
2 11 17 4 0 23 0 
3 12 13 5 0 14 0 
 
 
Table A.5 
KMnO4 CRBP Impact to D. magna (n) in 700ml CP water for 24h, 48h and 72h  
24h Treatment 
Day Control: CP KMnO4 CRBP: CP 
0 10 10 
1 7 8 
2 7 7 
3 6 6 
6 5 3 
7 4 1 
8 3 1 
48h Treatment 
Day Control: CP KMnO4 CRBP: CP 
0 37 32 
1 30 31 
2 32 30 
5 42 40 
6 54 48 
7 75 61 
72h Treatment 
Day Control: CP KMnO4 CRBP: CP 
0 23 25 
1 23 26 
4 28 40 
5 27 62 
6 59 82 
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Table A.6 
KMnO4 CRBP Impact to D. magna (n) in 800ml, 900ml and 1000ml CP water for 24h   
 800ml 900ml 1000ml 
Day Control: CP 
KMnO4 
CRBP: 
CP 
Control: 
CP 
KMnO4 
CRBP: CP 
Control: 
CP 
KMnO4 
CRBP: CP 
0 25 36 30 38 30 40 
1 25 35 26 36 29 38 
4 22 36 25 34 21 37 
5 22 24 25 29 14 28 
7 21 17 25 18 10 23 
8 21 16 26 26 10 23 
11 150 24 42 25 2 13 
12 147 21 45 26 2 13 
 
 
Table A.7 
Oxone® CRBP hour-by-hour Impact to D. magna (n) in 700ml CP for 24h  
24h Treatment 
Hour Oxone® CRBP: Country Park 
0 56 57 64 
1 26 43 55 
2 1 5 6 
3 0 0 0 
 
 
 
 
 
 
 
 
 
 
 
Table A.8 
KMnO4 CRBP vs. Oxone® CRBP Impact to D. magna (n) in 600ml CP water for 24h 
 
 
24h Treatment 
Day Control: 
Spring 
Control: 
CP 
KMnO4 CRBP: 
Spring 
Oxone® CRBP: 
Spring 
KMnO4 CRBP: 
CP 
Oxone® CRBP: 
CP 
0 10 12 11 12 14 11 
1 9 16 0 0 11 0 
2 9 17 0 0 9 0 
3 8 14 0 0 6 0 
4 0 3 0 0 1 0 
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